There was a numerical trend towards earlier diagnosis over time, with stage IIIA NSCLC diagnosed in 33.2% of the 2000–2002 cohort, versus 46.5% of the 2012–2013 cohort.
← all excerpts
Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.
1
—
—